[Form 4] IBEX Ltd Insider Trading Activity

Rhea-AI Filing Summary

IBEX Ltd. insider sale reported: Paul Joseph Inson, listed as Chief People Officer, reported a sale of 3,831 common shares on 09/12/2025 at a price of $38.94 per share. Following the sale, the filing shows Mr. Inson beneficially owns 3,266 shares. The Form 4 was signed by an attorney-in-fact on 09/15/2025. The document contains no additional explanation of the reason for the sale or any derivative transactions.

Positive

• Transparent compliance: Insider timely filed a Form 4 disclosing the sale
• No derivatives reported: Transaction appears limited to common shares with no related option activity

Negative

• Officer sale: An executive sold shares, reducing direct beneficial ownership
• Limited context: Filing contains no explanation for the sale or indication of a Rule 10b5-1 trading plan

Insights

Securities Analyst

TL;DR: Single insider sale of 3,831 shares, reduces direct holding to 3,266 shares; transaction appears routine and non-material.

The reported sale is a straightforward Section 16 disclosure: the Chief People Officer disposed of 3,831 common shares at $38.94 each. There are no accompanying derivative transactions, no schedule of additional sales, and no stated reason for the sale in the filing. For most investors this is a routine reporting of insider liquidity rather than an indicator of company-wide change.

Corporate Governance Expert

TL;DR: Single reported sale by an officer; governance implications are limited absent context on ownership or pattern.

The Form 4 documents a one-time disposition by an officer. The filing was executed by an attorney-in-fact, and no amendments or linked transactions are shown. Without recurring sales, option exercises, or disclosures about trading plans, this filing alone does not signal governance or policy changes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Inson Paul Joseph

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/12/2025		S		3,831	D	$38.94	3,266	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did IBEX (IBEX) insider Paul Joseph Inson report on Form 4?

He reported a sale of 3,831 common shares on 09/12/2025 at $38.94 per share, leaving beneficial ownership of 3,266 shares.

When was the Form 4 for IBEX filed and signed?

Transaction date is 09/12/2025 and the Form 4 was signed by an attorney-in-fact on 09/15/2025.

Did the Form 4 for IBEX report any derivative transactions or option exercises?

No. The filing shows only a non-derivative sale of common shares and contains no derivative entries.

How many shares does the reporting person own after the sale according to the filing?

3,266 shares of common stock are shown as beneficially owned following the reported transaction.

Does the Form 4 explain the reason for the insider sale?

No. The filing contains no explanation or note indicating the reason for the sale or whether it was under a trading plan.